Orabloc + Octocaine + Xylestesin-A

This entry refers to a comparative clinical study (NCT05804630) conducted by National Taiwan University Hospital evaluating three distinct dental local anesthetic formulations: Orabloc, Octocaine, and Xylestesin-A. Orabloc and Xylestesin-A are brand names for articaine hydrochloride (4%) combined with epinephrine, while Octocaine is a brand name for lidocaine hydrochloride (2%) with epinephrine. These agents are amide-type local anesthetics that function by blocking voltage-gated sodium channels, thereby inhibiting nerve impulse conduction. The study specifically investigates their efficacy and safety during the surgical extraction of impacted wisdom teeth in healthy adults using a split-mouth design.

Brand names

Xylestesin-A

Other names

Articaine and Lidocaine in Extraction of Wisdom Teeth